Organization
University Medicine Essen - Ruhrlandklinik
4 abstracts
Abstract
Surgical outcomes of patients with resectable non-small-cell lung cancer receiving neoadjuvant immunotherapy with nivolumab plus relatlimab or nivolumab: Findings from the prospective, randomized, multicentric phase II study NEOpredict-Lung.Org: West German Cancer Center, University Hospital Essen, Jessa Hospital, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Department of Pathology and Neuropathology,
Abstract
N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.Org: University of Heidelberg, NCT Heidelberg, Heidelberg University Hospital, Department of Neurology and Hematology-Oncology, Department of Neuroradiology,
Abstract
Early detection of lung cancer using small RNAs.Org: Hummingbird Diagnostics, Klinikverbund Allgäu, Klinikum Konstanz, Translational Lung Research Center Heidelberg, University Hospital Essen,
Abstract
Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF.Org: University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, University Hospital Regensburg, Medical Center - University of Freiburg, Carl Gustav Carus University Hospital Dresden,